A detailed history of American Portfolios Advisors transactions in Glaukos Corp stock. As of the latest transaction made, American Portfolios Advisors holds 176 shares of GKOS stock, worth $24,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
176
Holding current value
$24,108
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$46.84 - $58.49 $8,243 - $10,294
176 New
176 $9.37 Million
Q3 2021

Mar 22, 2023

BUY
$47.43 - $84.23 $30,829 - $54,749
650 Added 369.32%
826 $39.8 Million
Q2 2021

Mar 22, 2023

BUY
$73.06 - $97.7 $47,489 - $63,505
650 Added 369.32%
826 $70.1 Million
Q1 2021

Mar 22, 2023

BUY
$70.43 - $97.42 $45,779 - $63,323
650 Added 369.32%
826 $69.3 Million
Q4 2020

Mar 22, 2023

BUY
$48.9 - $75.26 $31,785 - $48,919
650 Added 369.32%
826 $62.2 Million
Q3 2020

Mar 22, 2023

BUY
$37.23 - $50.97 $24,199 - $33,130
650 Added 369.32%
826 $40.9 Million
Q2 2020

Mar 24, 2023

SELL
$28.78 - $46.83 $10,073 - $16,390
-350 Reduced 29.76%
826 $31.7 Million
Q1 2020

Mar 24, 2023

BUY
$25.53 - $70.14 $25,530 - $70,140
1,000 Added 568.18%
1,176 $36.3 Million
Q4 2019

Mar 24, 2023

BUY
$54.18 - $65.64 $51,091 - $61,898
943 Added 535.8%
1,119 $61 Million
Q2 2019

Mar 24, 2023

BUY
$63.59 - $78.71 $61,682 - $76,348
970 Added 551.14%
1,146 $86.4 Million
Q1 2019

Mar 24, 2023

BUY
$50.75 - $80.54 $2,943 - $4,671
58 Added 4.81%
1,264 $99.1 Million
Q4 2018

Mar 24, 2023

BUY
$52.18 - $67.93 $11,009 - $14,333
211 Added 21.21%
1,206 $67.7 Million
Q3 2018

Mar 24, 2023

BUY
$38.13 - $68.37 $31,228 - $55,995
819 Added 465.34%
995 $64.6 Million
Q2 2018

Mar 24, 2023

BUY
$27.62 - $44.51 $8,810 - $14,198
319 Added 47.19%
995 $40.4 Million
Q1 2018

Mar 24, 2023

BUY
$26.05 - $34.5 $13,025 - $17,250
500 Added 284.09%
676 $20.8 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.52B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.